Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 May 2;12(5):418.
doi: 10.3390/pharmaceutics12050418.

Nanoparticles to Improve the Efficacy of Vaccines

Cheol-Heui Yun  1 , Chong-Su Cho  1
Affiliations
Editorial

Nanoparticles to Improve the Efficacy of Vaccines

Cheol-Heui Yun et al. Pharmaceutics. .

Abstract

This editorial aims to summarize the nine scientific papers that contributed to the Special Issue entitled 'Nanoparticles to Improve the Efficacy of Vaccines'.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. World Health Organization, Global Vaccine Action Plan 2011–2020. [(accessed on 1 May 2020)]; Available online: https://www.who.int/immunization/global_vaccine_action_plan/GVAP_doc_201...
    1. Kim C.G., Kye Y.C., Yun C.H. The Role of Nanovaccine in Cross-Presentation of Antigen-Presenting Cells for the Activation of CD8+ T Cell Responses. Pharmaceutics. 2019;11:612. doi: 10.3390/pharmaceutics11110612. - DOI - PMC - PubMed
    1. Kye Y.C., Park S.M., Shim B.S., Firdous J., Kim G., Kim H.W., Ju Y.J., Kim C.G., Cho C.S., Kim D.W., et al. Intranasal immunization with pneumococcal surface protein A in the presence of nanoparticle forming polysorbitol transporter adjuvant induces protective immunity against the Streptococcus pneumoniae infection. Acta Biomater. 2019;9:362–372. doi: 10.1016/j.actbio.2019.03.049. - DOI - PubMed
    1. Barnowski C., Kadzioch N., Damm D., Yan H., Temchura V. Advantages and Limitations of Integrated Flagellin Adjuvants for HIV-Based Nanoparticle B-Cell Vaccines. Pharmaceutics. 2019;11:204. doi: 10.3390/pharmaceutics11050204. - DOI - PMC - PubMed
    1. Kang H.J., Lee S.H., Kim M.J., Chu K.B., Lee D.H., Chopra M., Choi H.J., Park H., Jin H., Quan F.S. Influenza Virus-Like Particles Presenting both Toxoplasma gondii ROP4 and ROP13 Enhance Protection against T. gondii Infection. Pharmaceutics. 2019;11:342. doi: 10.3390/pharmaceutics11070342. - DOI - PMC - PubMed

Publication types

LinkOut - more resources